Avidity Biosciences (RNA)
(Real Time Quote from BATS)
$47.95 USD
-0.56 (-1.15%)
Updated Oct 2, 2024 09:50 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Avidity Biosciences, Inc. (RNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$67.56 | $96.00 | $51.00 | 39.27% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Avidity Biosciences, Inc. comes to $67.56. The forecasts range from a low of $51.00 to a high of $96.00. The average price target represents an increase of 39.27% from the last closing price of $48.51.
Analyst Price Targets (9 )
Broker Rating
Avidity Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.10 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.10 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, nine are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 90% and 10% of all recommendations. A month ago, Strong Buy made up 90%, while Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 8 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.10 | 1.10 | 1.10 | 1.11 | 1.11 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/24/2024 | Goldman Sachs | Corinne Johnson | Not Available | Strong Buy |
9/9/2024 | Cantor Fitzgerald & Co | Eric Schmidt | Strong Buy | Strong Buy |
8/28/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
8/13/2024 | Needham & Company | Joseph R Stringer | Moderate Buy | Moderate Buy |
6/14/2024 | Wells Fargo Securities | Yanan Zhu | Strong Buy | Strong Buy |
6/12/2024 | SVB Securities | Joseph P Schwartz | Strong Buy | Strong Buy |
6/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/12/2024 | Evercore Partners | Gavin Clark-Gartner | Not Available | Strong Buy |
4/1/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.10 |
ABR (Last week) | 1.10 |
# of Recs in ABR | 10 |
Average Target Price | $67.56 |
LT Growth Rate | 3.70% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | -0.80 |
RNA FAQs
Avidity Biosciences, Inc. (RNA) currently has an average brokerage recommendation (ABR) of 1.10 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for Avidity Biosciences, Inc. (RNA) is $67.56. The current on short-term price targets is based on 5 reports.
The forecasts for Avidity Biosciences, Inc. (RNA) range from a low of $51 to a high of $96. The average price target represents a increase of $39.27 from the last closing price of $48.51.
The current UPSIDE for Avidity Biosciences, Inc. (RNA) is 39.27%
Based on short-term price targets offered by nine analysts, the average price target for Avidity Biosciences, Inc. comes to $67.56. The forecasts range from a low of $51.00 to a high of $96.00. The average price target represents an increase of 39.27% from the last closing price of $48.51.